Ocugen
MALVERN, PA · CIK 0001372299 · Biotech · Public
OCU400, a gene therapy for retinitis pigmentosa and inherited retinal disease
ocugen.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $126M
- 6 Form D · May 2020
- 77 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 28
- 6 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020122014201620182020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $34,300,000 | |
| Private capital raised | Form D · SEC | $37,488,679 | |
| Private capital raised | Form D · SEC | $10,323,988 | |
| Private capital raised | Form D · SEC | $30,000,001 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $395 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $14,283,724 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2165 | NEMALIFE INC | — | — |
| 2166 | PRIME LABS INC | — | — |
| 2167 | Immunovant | — | $450M |
| 2168 | Ocugen | — | $126M |
| 2169 | VISIONARY PHARMACEUTICALS, INC. | — | — |
| 2170 | Excision BioTherapeutics Inc. | — | $71M |
| 2171 | Context Therapeutics | — | $100M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kirk AndrianoExecutive Officer
- Rasappa ArumughamExecutive Officer
- Joshua BaltzellDirector
- Kelly BeckExecutive Officer
- Brian CallahanExecutive Officer
- Kristen CastilloDirector
- Prabhavathi FernandesDirector
- Patrick FortuneDirector
- David GillDirector
- Peter GreenleafDirector · Executive Officer
- Adam GridleyDirector · Executive Officer
- John JohnsonDirector
- Daniel JorgensenExecutive Officer
- Uday KompellaDirector
- Garheng KongDirector
- Garheng Kong, M.D., Ph.DDirector
- Garheng Kong, M.D., Ph.D.Director
- Ramesh KumarDirector
- Michael LewisDirector
- Jonathan LieberDirector
- Kevin McArdleExecutive Officer
- Shankar MusunuriDirector · Executive Officer
- Patrick O'DonnellDirector · Executive Officer
- Manish PottiDirector
- Philip PressDirector
- Kevin RakinDirector
- Dominic RedfernDirector
- Harry ReinDirector
- Sanjay SubramanianExecutive Officer
- Vijay TammaraExecutive Officer
- Laurence TarrantExecutive Officer
- Suha TaspolatogluDirector
- Junge ZhangDirector
Patents
- Cell-support Matrix Having Narrowly Defined Uniformly Vertically And Non-randomly Organized Porosity And Pore Density And A Method For Preparation Thereofgranted
- Cell-Support Matrix Having Narrowly Defined Uniformly Vertically and Non-Randomly Organized Porosity and Pore Density and a Method For Preparation Thereofapplication
- Multicistronic Vaccine and Methods for Producing and Using the Sameapplication
- Treatment of Neurological Disorder Using NHRapplication
- Method For Use Of A Double-structured Tissue Implant For Treatment Of Tissue Defectsapplication
- Method For Use Of A Double-structured Tissue Implant For Treatment Of Tissue Defectsgranted
- Neocartilage Constructs Using Universal Cellsapplication
- Scaffold With Adhesive For Articular Cartilage Repairapplication
- Adeno-associated Virus Vector Mediated Gene Therapy For Ophthalmic Diseasesapplication
- Preservative Free Ocular Compositions And Methods For Using The Same For Treating Dry Eye Disease And Other Eye Disordersgranted
- Ophthalmic Compositions And Methods Of Usegranted
- Ophthalmic Compositions And Methods Of Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.